Skip to main content
. 2019 Jan 9;17:8. doi: 10.1186/s12916-018-1233-1

Fig. 3.

Fig. 3

Molecular heterogeneity of HER2-positive breast cancer. Intrinsic subtype distribution in baseline tumors (a), according to hormonal receptor status (b, c), and in surgical tumors (d). e Pathological complete response (pCR) rates of the intrinsic subtypes identified at baseline